BenQ Medical and Brain Navi Partner to Advance Neurosurgical Robotics in China
ZHUBEI, March 19, 2025 /PRNewswire/ — Brain Navi Biotechnology, a key innovator in neurosurgical robotics, has announced a strategic partnership with BenQ Medical Technology to introduce and commercialize the NaoTrac neurosurgical navigation robot in the Chinese market. This collaboration aligns with Brain Navi’s 2025 globalization strategy, emphasizing localized partnerships to accelerate market entry and enhance clinical adoption.
China’s surgical robotics industry is experiencing rapid growth. Market research from Frost & Sullivan projects the surgical robot market to surpass USD 3 billion by 2026, reaching USD 9.5 billion by 2030. With the increasing demand for enhanced precision and automation in neurosurgery, Brain Navi’s NaoTrac, an advanced AI-powered navigation system, is poised to significantly improve patient outcomes.
Through this partnership, BenQ Medical Technology will leverage its broad hospital network across China to facilitate the clinical deployment of NaoTrac. This collaboration is further supported by China’s 14th Five-Year Plan for the Development of the Medical Equipment Industry, which aims to foster domestic innovation and promote intelligent medical solutions.
“This collaboration marks BenQ Medical Technology as a key step in integrating surgical robots and expanding applications in smart operating rooms,” stated Michael Kuan, the President of BenQ Medical Technology. “With the rapid advancements in AI and robotic technology, intelligent healthcare is the future. By working with Brain Navi, we are committed to driving the adoption of surgical robotics in China, which will provide patients with precise, safe, and innovative solutions.”
Dr. Jerry Chen, CEO of Brain Navi, underscored the value of regional partnerships, stating, “NaoTrac has already been used in various medical centers throughout Asia, Latin America, and Europe. Partnering with BenQ Medical Technology provides us with a robust entry point into the Chinese market, where localization is essential for success. We are confident in accelerating the adoption of neurosurgical robotics in China by combining our AI-driven surgical technology with BenQ Medical Technology’s strong market presence.”
As part of its 2025 strategy, Brain Navi continues to expand globally, with key focuses in EMEA, the Asia-Pacific region, and Latin America. The company is committed to providing localized support through distributor empowerment, hospital collaborations, and advanced training programs tailored to the needs of neurosurgeons worldwide. By fostering strong alliances with distributors and hospital networks, the company aims to ensure the seamless integration of neurosurgical robotics into regional healthcare systems.
Brain Navi will present NaoTrac at the upcoming AANS (American Association of Neurological Surgeons) Annual Meeting, scheduled for April 25–28, 2025, in Boston, MA. This event provides an opportunity for distributors, hospitals, and neurosurgeons to experience the future of neurosurgical robotics firsthand.
About BenQ Medical Technology
BenQ Medical Technology, a subsidiary of BenQ Group, is a leading provider of advanced medical devices and healthcare solutions. Founded in Taiwan in 1989, the company specializes in surgical equipment, imaging systems, and patient care solutions. Holding global certifications like ISO 13485 and ISO 9001, BenQ Medical maintains high-quality standards in medical technology. Through innovation and strategic partnerships, the company is expanding its global footprint, delivering intelligent healthcare solutions that enhance both patient care and surgical precision worldwide. For more information, visit www.benqmedicaltech.com.
About Brain Navi
Brain Navi Biotechnology, a leading Taiwanese surgical robotic company, focuses on designing and developing innovative navigation and robotic surgery technologies. Their proprietary Surface Mapping Auto-Registration Technology (SMART) represents a major surgical breakthrough, integrating machine vision, robotics, and AI for efficient surgical procedures and real-time imaging, ensuring minimally invasive outcomes. NaoTrac’s rapid patient registration and automatic surgical instrument registration enable surgeons to plan trajectories easily, with the robot providing precise autonomous navigation towards the desired target.
